Advanced

Antibiotic prophylaxis in urological surgery, a European viewpoint.

Grabe, Magnus LU (2011) In International Journal of Antimicrobial Agents 38. p.58-63
Abstract
Surgical site infections (SSI) including urinary tract infections (UTI) cause a significant morbidity in urological surgery. Antibiotic prophylaxis is one of several factors impacting on infection rates. Antibiotic prophylaxis is relevant only for clean and clean-contaminated operations and in the absence of bacterial growth in the urine. Strict classification of urological procedures is lacking, but a proposal is presented elsewhere. Only TURP and transrectal core prostate biopsy are well documented. The present review confirms that there is a lack of hard data, insufficient consistency in classification and definitions, and that new well-powered RCT and large multicentre quality cohort studies including risk factor analysis are necessary... (More)
Surgical site infections (SSI) including urinary tract infections (UTI) cause a significant morbidity in urological surgery. Antibiotic prophylaxis is one of several factors impacting on infection rates. Antibiotic prophylaxis is relevant only for clean and clean-contaminated operations and in the absence of bacterial growth in the urine. Strict classification of urological procedures is lacking, but a proposal is presented elsewhere. Only TURP and transrectal core prostate biopsy are well documented. The present review confirms that there is a lack of hard data, insufficient consistency in classification and definitions, and that new well-powered RCT and large multicentre quality cohort studies including risk factor analysis are necessary to improve recommendations for antibiotic prophylaxis in urologic surgery. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
International Journal of Antimicrobial Agents
volume
38
pages
58 - 63
publisher
Elsevier
external identifiers
  • wos:000298141200008
  • pmid:21996404
  • scopus:82655173802
ISSN
1872-7913
DOI
10.1016/j.ijantimicag.2011.09.008
language
English
LU publication?
yes
id
36bb5300-190e-425e-9881-976a5d188058 (old id 2200535)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/21996404?dopt=Abstract
date added to LUP
2011-11-02 10:04:41
date last changed
2017-08-27 05:44:47
@article{36bb5300-190e-425e-9881-976a5d188058,
  abstract     = {Surgical site infections (SSI) including urinary tract infections (UTI) cause a significant morbidity in urological surgery. Antibiotic prophylaxis is one of several factors impacting on infection rates. Antibiotic prophylaxis is relevant only for clean and clean-contaminated operations and in the absence of bacterial growth in the urine. Strict classification of urological procedures is lacking, but a proposal is presented elsewhere. Only TURP and transrectal core prostate biopsy are well documented. The present review confirms that there is a lack of hard data, insufficient consistency in classification and definitions, and that new well-powered RCT and large multicentre quality cohort studies including risk factor analysis are necessary to improve recommendations for antibiotic prophylaxis in urologic surgery.},
  author       = {Grabe, Magnus},
  issn         = {1872-7913},
  language     = {eng},
  pages        = {58--63},
  publisher    = {Elsevier},
  series       = {International Journal of Antimicrobial Agents},
  title        = {Antibiotic prophylaxis in urological surgery, a European viewpoint.},
  url          = {http://dx.doi.org/10.1016/j.ijantimicag.2011.09.008},
  volume       = {38},
  year         = {2011},
}